UK gets social media presence

Share this article:
The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued “informal guidance” on digital communications, and while it's more than FDA has offered, it's not much to go on.
The guidance, which takes the form of a Q&A, is mainly an interpretation of the industry's Code of Practice applied to social media and the internet. Short version: as in any other medium, companies can communicate only non-promotional information about products to the public, and only in response to a direct inquiry. However, the guidance does suggest that companies could post more basic product info on their websites.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?